Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis

Anticancer Research

Volumn 31, Issue 3, 2011, Pages 933-938

  Tahara, Tomomitsu ^a,c   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Okubo, Masaaki ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Yonemura, Joh ^a   Kmiya, Yoshio ^a   Ishizuka, Takamitsu ^a   Fujita, Hiroshi ^a   Nagasaka, Mitsuo ^a   Yamada, Hideto ^b   Hirata, Ichiro ^a   Arisawa, Tomiyasu ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NONE   (United States)

Author keywords

CD14; DNA methylation; MBL; p22PHOX; Polymorphism; Ulcerative colitis

Indexed keywords

CD14 ANTIGEN; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1BETA; MANNAN BINDING LECTIN; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN P14; PROTEIN P16; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ADULT; ARTICLE; CARCINOGENESIS; CODON; COLON MUCOSA; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE CONTROL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; RECTUM MUCOSA; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 79956093054     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Head KA and Jurenka JS: Inflammatory bowel disease Part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 8: 247-283, 2003. (Pubitemid 37099887)
2. Lakatos L and Lakatos PL: Etiopathogenesis of inflammatory bowel diseases. Orv Hetil 144: 1853-1860, 2003.
3. Hugot JP: Inflammatory bowel disease: causes and consequences. Best Pract Res Clin Gastroenterol 18: 447-449, 2004.
4. Ekbom A, Helmick C, Zack M and Adami HO: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323: 1228-1233, 1990. (Pubitemid 20366527)
5. Eaden JA, Abrams KR and Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535, 2001. (Pubitemid 32234798)
6. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R and Ekbom A: Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120: 1356-1362, 2001. (Pubitemid 32322309)
7. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM and Lindor NM: Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 115: 1079-1083, 1998. (Pubitemid 28485597)
8. Jayaram H, Satsangi J and Chapman RW: Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut 48: 430-434, 2001.
9. Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC and Forbes A: Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 53: 1813-1816, 2004.
10. Bernstein CN, Blanchard JF, Kliewer E and Wajda A: Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91: 854-862, 2001. (Pubitemid 32173312)
11. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE and Baylin SB: Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 4: 536-540, 1994. (Pubitemid 24308343)
12. Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP: Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 23: 5489-5494, 1998. (Pubitemid 28551135)
13. Sato F, Harpaz N, Shibata D, Xu Y, Yin J, Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM and Meltzer SJ: Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 62: 1148-1151, 2002. (Pubitemid 34160301)
14. Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573-3537, 2001.
15. Bian YS, Osterheld MC, Fontolliet C, Bosman FT and Benhattar J: p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 122: 1113-1121, 2002. (Pubitemid 34267292)
16. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL and Reid BJ: p16 (INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 61: 8284-8289, 2001. (Pubitemid 33091623)
17. Kaneto H, Sasaki S, Yamamoto H, Itoh F, Toyota M, Suzuki H, Ozeki I, Iwata N, Ohmura T, Satoh T, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Omata M and Imai K: Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 48: 372-377, 2001. (Pubitemid 32269566)
18. Garrity-Park MM, Loftus EV Jr., Sandborn WJ, Bryant SC and Smyrk TC: Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Am J Gastroenterol 105: 1610-1619, 2010.
19. Issa JP: GpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249: 101-118, 2000.
20. Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826,1996. (Pubitemid 26296693)
21. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB and Herman JG: Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60: 129-133, 2000. (Pubitemid 30058742)
22. Drozdzik M, Bialecka M, Mysliwiec K, Honczarenko K, Stankiewicz J and Sych Z: Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics 13: 259-263, 2003. (Pubitemid 36583992)
23. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A and Shioda T: Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96: 4581-4585, 1999. (Pubitemid 29190379)
24. Fekete A, Treszl A, Tóth-Heyn P, Vannay A, Tordai A, Tulassay T and Vásárhelyi B: Association between heat-shock protein 72 gene polymorphism and acute renal failure in premature neonates. Pediatr Res 54: 452-455, 2003. (Pubitemid 37159111)
25. Tahara T, Shibata T, Wang F, Nakamura M, Okubo M, Yoshioka D, Sakata M, Nakano H, Hirata I and Arisawa T: Association of polymorphism of the p22PHOX component of NADPH oxidase in gastroduodenal diseases in Japan. Scand J Gastroenterol 44: 296-300, 2009.
26. Hubacek JA, Rothe G, Pit'ha J, Skodova Z, Stanek V, Poledne R and Schmitz G: C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220, 1999. (Pubitemid 29293428)
27. Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T and Nukiwa T: Mannose-binding lectin polymorpism is a modulating factor in repeated respiratory infections. Chest 126: 95-97, 2004.
28. Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, Sugimura H and Hishida A: Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 22: 51-59, 2007. (Pubitemid 44953416)
29. Tahara T, Arisawa T, Wang F, Shibata T, Nakamura M, Sakata M, Hirata I and Nakano H: Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 98: 1790-1794, 2007. (Pubitemid 47487917)
30. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996,
31. Turner MW and Hamvas RMJ: Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2: 305-322, 2000. (Pubitemid 32041159)
32. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY and Yamaoka Y: Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123: 1793-1803, 2002. (Pubitemid 35408303)
33. Wallace JL, Cucala M, Mugridge K and Parente L: Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261: G559-564, 1991.
34. Eisen DP and Minchinton RM: Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 37: 1496-1505, 2003. (Pubitemid 37494678)
35. Babior BM: NADPH oxidase: an update. Blood 93: 1464-1476, 1999.
36. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R and Channon KM: Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22PHOX gene on vascular superoxide production in atherosclerosis. Circulation 102: 1744-1747, 2000.